Trevi Therapeutics, Inc. Share Price
TRVITrevi Therapeutics, Inc. Stock Performance
Open $12.10 | Prev. Close $12.09 | Circuit Range N/A |
Day Range $11.97 - $12.30 | Year Range $2.36 - $12.30 | Volume 51,502 |
Average Traded $12.16 |
Trevi Therapeutics, Inc. Share Price Chart
About Trevi Therapeutics, Inc.
Trevi Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of investigational therapy for the treatment of chronic cough in patients with idiopathic pulmonary fibrosis (IPF) and non-IPF interstitial lung disease, and refractory chronic cough. The company is developing Haduvio, an oral extended-release formulation of nalbuphine, which is in phase 2b Cough Reduction in IPF with nalbuphine ER clinical trial for treatment of chronic cough in patients with IPF; phase 2 clinical trial in patients with pruritus; and phase 2b/3 clinical trial in patients with prurigo nodularis. Trevi Therapeutics, Inc. has a license agreement with Endo Pharmaceuticals Inc. to develop and commercialize products incorporating nalbuphine hydrochloride in various formulations. The company was incorporated in 2011 and is headquartered in New Haven, Connecticut.
Trevi Therapeutics, Inc. Historical Data
| Day | Open | Close | Change % |
|---|---|---|---|
12-Nov-25 | $12.10 | $11.92 | +0.00% |
12-Nov-25 | $12.10 | $11.92 | -1.32% |
11-Nov-25 | $11.73 | $12.08 | +3.38% |
10-Nov-25 | $11.14 | $11.69 | +6.03% |
07-Nov-25 | $10.96 | $11.02 | -0.09% |
06-Nov-25 | $10.67 | $11.03 | +3.67% |
05-Nov-25 | $10.46 | $10.64 | -2.03% |
FAQs on Trevi Therapeutics, Inc. Share Price
Can I buy Trevi Therapeutics, Inc. shares in India?
What is the share price of Trevi Therapeutics, Inc.?
What is the 5 year returns of Trevi Therapeutics, Inc.?
What are the high & low stock price of Trevi Therapeutics, Inc. today?
What is the 52-week high and low of Trevi Therapeutics, Inc. stock?